Clinical Trials Directory

Trials / Completed

CompletedNCT00153738

Phytosterol Supplementation and Cardiovascular Risk

Effectiveness of Phytosterol Supplementation on Select Indices of Cardiovascular Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (planned)
Sponsor
The Cooper Institute · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation.

Detailed description

This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation. The study recruited 72 men and women 20-70 years of age with mild hypercholesteremia (\>130 mg/dl LDL-C). They were assigned to 1 of 2 groups. Participants ingested the supplement or a placebo for 12 weeks, with an interim assessment at 6 weeks. Participants agreed to maintain current diet, medication, and exercise habits and to not donate blood during the trial.

Conditions

Interventions

TypeNameDescription
DRUGphytosterol

Timeline

Start date
2004-03-01
Completion
2005-08-01
First posted
2005-09-12
Last updated
2014-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00153738. Inclusion in this directory is not an endorsement.

Phytosterol Supplementation and Cardiovascular Risk (NCT00153738) · Clinical Trials Directory